Home / News / India News / Article /
Mumbai, parts of Maharashtra to get COVID-19 drug soon
Updated On: 25 June, 2020 03:15 PM IST | Mumbai | IANS
Covifor is the first generic brand of Remdesivir which is indicated for the treatment of Covid-19 patients in adults and children, hospitalised with severe symptoms of the disease
Listen to this article :
This picture has been used for representational purpose only
Covifor, the generic version of Covid-19 drug Remdesivir, will be available in India for Rs 5,400 per 100 mg vial, Hyderabad-based Hetero Labs announced on Wednesday.
Following the approval to Covifor by the Drug Controller General of India , Hetero Healthcare Ltd, a group company of Hetero, announced that it is set to deliver the first set of 20,000 vials.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT